Stocks · News reference
Barclays Initiates Coverage On Anteris Technologies Glb with Equal-Weight Rating, Announces Price Target of $10
Barclays analyst Matt Miksic initiates coverage on Anteris Technologies Glb (NASDAQ:AVR) with a Equal-Weight rating and announces Price Target of $10.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Anteris Technologies Global Corp. (AVR)
Filed: 2026-09-23 AccNo: 0001140361-26-037392 Size: 189 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Anteris to Present at September Healthcare Investor Conferences
Anteris Technologies Global Corp. announced that Vice Chairman and CEO Wayne Paterson will present at three major healthcare conferences in September 2026: Cantor Global Healthcare Conference (Sept 9), Wells Fargo 21st Annual Healthcare Conference (Sept 10), and Morgan Stanley 24th Annual Global Healthcare Conference (Sept 14). The company is showcasing its DurAVR® Transcatheter Heart Valve, a biomimetic device designed to treat aortic stenosis.